Our senior market strategist explains which ETFs offer exposure to high-powered biotech growth, without T. Rex-sized risk.

Investors in biotech companies approach their investments with the mindset of praying or scratching a lottery ticket, as the success rate of new drug development is extremely low and the costs are ...

As AI tools become more prevalent in the life sciences, biotechnology companies need to evaluate AI’s impact on their ability to protect the results of their research. Recent U.S. Patent and Trademark ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the age and credit for inventing it. The CRISPR patents are back in play. On ...

AI as defined by the UK Intellectual Property Office (‘UK IPO’) and European Patent Office (‘EPO’) Applications of AI in biotechnology How biotechnology companies can leverage AI to drive innovation ...

Jason P Rogers of James & Wells provides a guide to protecting pharmaceutical and biotech inventions in New Zealand, and previews the changes expected under proposed changes to the Patents Act In New ...

Artificial intelligence is beginning to transform patent practice, but for chemistry and biotech, the challenges remain unique. How well do today’s AI tools truly understand complex scientific ...

Artificial intelligence is beginning to transform patent practice, but for chemistry and biotech, the challenges remain unique. How well do today’s AI tools truly understand complex scientific ...